Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
Cancer Treatment and Research Communications|May 25, 2021
Nano Diaminopropane tetrac and integrin αvβ3 expression in different cancer types: Anti-cancer efficacy and SafetyKavitha Godugu, Thangirala Sudha, Paul J Davis, et al.
Nanomedicine (London, England)|September 14, 2022
Antitumor/anti-angiogenesis efficacy of epigallocatechin gallate nanoformulated with antioxidant in melanomaThangirala Sudha, Taher A Salaheldin, Noureldien He Darwish, et al.
Biomedicines|April 23, 2022
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic CancerThangirala Sudha, Kavitha Godugu, Gennadi V Glinsky, et al.
Biomedicines|October 31, 2025
RETRACTED: Sudha et al. Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol, a Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist as a Radio- and Chemo-Sensitizer in Pancreatic Cancer. <i>Biomedicines</i> 2022, <i>10</i>, 795Thangirala Sudha, Kavitha Godugu, Gennadi V Glinsky, et al.
Cancer Letters|January 26, 2013
OT-404, multi-targeted anti-cancer agent affecting tumor proliferation, chemo-resistance, and angiogenesisAbdelhadi Rebbaa, Ghanshyam Patil, Murat Yalcin, et al.
Bioconjugate Chemistry|November 13, 2019
Triazole Modified Tetraiodothyroacetic Acid Conjugated to Polyethylene Glycol: High Affinity Thyrointegrin α<sub>v</sub>β<sub>3</sub> Antagonist with Potent Anticancer Activities in Glioblastoma MultiformeMehdi Rajabi, Kavitha Godugu, Thangirala Sudha, et al.
International Journal of Oncology|December 23, 2014
Anti-metastasis efficacy and safety of non-anticoagulant heparin derivative versus low molecular weight heparin in surgical pancreatic cancer modelsReem Alyahya, Thangirala Sudha, Michael Racz, et al.
Comprehensive Physiology|January 13, 2016
Thyroid Hormone, Hormone Analogs, and AngiogenesisPaul J Davis, Thangirala Sudha, Hung-Yun Lin, et al.
Molecular Vision|September 15, 2012
Nano chitosan peptide as a potential therapeutic carrier for retinal delivery to treat age-related macular degenerationMelamangalam S Jayaraman, Dhruba J Bharali, Thangirala Sudha, et al.
Molecules (Basel, Switzerland)|April 5, 2020
Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer ModelsThangirala Sudha, Ali H El-Far, Deena S Mousa, et al.
Pageof 5